{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:24:20Z","timestamp":1790753060969,"version":"4.1.0"},"reference-count":43,"publisher":"Spandidos Publications","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncol Lett"],"DOI":"10.3892\/ol.2018.9011","type":"journal-article","created":{"date-parts":[[2018,6,22]],"date-time":"2018-06-22T12:31:53Z","timestamp":1529670713000},"source":"Crossref","is-referenced-by-count":14,"title":["Upregulation of miR\u2011375 inhibits human liver cancer cell growth by modulating cell proliferation and apoptosis via targeting ErbB2"],"prefix":"10.3892","author":[{"given":"Lina","family":"Li","sequence":"first","affiliation":[{"name":"Department of Digestive Diseases, Daqing Longnan Hospital, Daqing, Heilongjiang 163453, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Jia","sequence":"additional","affiliation":[{"name":"Department of Digestive Diseases, Daqing Longnan Hospital, Daqing, Heilongjiang 163453, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Ding","sequence":"additional","affiliation":[{"name":"The First Department of General Surgery, Daqing Oilfield General Hospital, Daqing, Heilongjiang 163000, P.R. China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"2249","published-online":{"date-parts":[[2018,6,22]]},"reference":[{"key":"key20200714083519_b1-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1038\/nature08170","article-title":"Argonaute HITS-CLIP decodes microRNA-mRNA interaction maps","volume":"460","author":"Chi","year":"2009","journal-title":"Nature"},{"key":"key20200714083519_b2-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1002\/mrd.22272","article-title":"Small RNA regulation of reproductive function","volume":"81","author":"Hale","year":"2014","journal-title":"Mol Reprod Dev"},{"key":"key20200714083519_b3-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1002\/path.2806","article-title":"MiRNAs in human cancer","volume":"223","author":"Farazi","year":"2011","journal-title":"J Pathol"},{"key":"key20200714083519_b4-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1016\/S0092-8674(04)00045-5","article-title":"MicroRNAs: Genomics, biogenesis, mechanism, and function","volume":"116","author":"Bartel","year":"2004","journal-title":"Cell"},{"key":"key20200714083519_b5-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1053\/j.gastro.2007.05.022","article-title":"MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer","volume":"133","author":"Meng","year":"2007","journal-title":"Gastroenterology"},{"key":"key20200714083519_b6-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"635","DOI":"10.1016\/j.cell.2005.01.014","article-title":"RAS is regulated by the let-7 microRNA family","volume":"120","author":"Johnson","year":"2005","journal-title":"Cell"},{"key":"key20200714083519_b7-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1101\/gad.1540407","article-title":"The tumor suppressor microRNA let-7 represses the HMGA2 oncogene","volume":"21","author":"Lee","year":"2007","journal-title":"Genes Dev"},{"key":"key20200714083519_b8-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1038\/nrc1997","article-title":"MicroRNA signatures in human cancers","volume":"6","author":"Calin","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"key20200714083519_b9-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/ncb2039","article-title":"Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA","volume":"12","author":"Ding","year":"2010","journal-title":"Nat Cell Biol"},{"key":"key20200714083519_b10-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1016\/j.cell.2009.04.021","article-title":"Therapeutic microRNA delivery suppresses tumorigenesis in a murine liver cancer model","volume":"137","author":"Kota","year":"2009","journal-title":"Cell"},{"key":"key20200714083519_b11-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1158\/1078-0432.CCR-07-0523","article-title":"Association of MicroRNA expression in hepatocellular carcinomas with hepatitis infection, cirrhosis, and patient survival","volume":"14","author":"Jiang","year":"2008","journal-title":"Clin Cancer Res"},{"key":"key20200714083519_b12-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"6092","DOI":"10.1158\/0008-5472.CAN-06-4607","article-title":"Cyclin G1 is a target of miR-122a, a microRNA frequently down-regulated in human hepatocellular carcinoma","volume":"67","author":"Gramantieri","year":"2007","journal-title":"Cancer Res"},{"key":"key20200714083519_b13-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1111\/j.1440-1746.2007.05223.x","article-title":"Microarray analysis of microRNA expression in hepatocellular carcinoma and non-tumorous tissues without viral hepatitis","volume":"23","author":"Huang","year":"2008","journal-title":"J Gastroenterol Hepatol"},{"key":"key20200714083519_b14-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1002\/hep.22160","article-title":"Identification of metastasis-related microRNAs in hepatocellular carcinoma","volume":"47","author":"Budhu","year":"2008","journal-title":"Hepatology"},{"key":"key20200714083519_b15-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1002\/hep.22158","article-title":"MicroRNA gene expression profile of hepatitis C virus-associated hepatocellular carcinoma","volume":"47","author":"Varnholt","year":"2008","journal-title":"Hepatology"},{"key":"key20200714083519_b16-ol-0-0-9011","first-page":"870","volume-title":"Robbins & Cotran Pathologic Basis of Disease","author":"Kumar","year":"2015","edition":"9th edition"},{"key":"key20200714083519_b17-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1056\/NEJMra1001683","article-title":"Hepatocellular carcinoma","volume":"365","author":"El-Serag","year":"2011","journal-title":"N Engl J Med"},{"key":"key20200714083519_b18-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/S0140-6736(11)61347-0","article-title":"Hepatocellular carcinoma","volume":"379","author":"Forner","year":"2012","journal-title":"Lancet"},{"key":"key20200714083519_b19-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1186\/1471-2407-9-389","article-title":"Predicting prognosis in hepatocellular carcinoma after curative surgery with common clinicopathologic parameters","volume":"9","author":"Hao","year":"2009","journal-title":"BMC Cancer"},{"key":"key20200714083519_b20-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"2257","DOI":"10.1073\/pnas.0510565103","article-title":"A microRNA expression signature of human solid tumors defines cancer gene targets","volume":"103","author":"Volinia","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200714083519_b21-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"856","DOI":"10.2353\/ajpath.2008.080096","article-title":"Elevated expression of the miR-17-92 polycistron and miR-21 in hepadnavirus-associated hepatocellular carcinoma contributes to the malignant phenotype","volume":"173","author":"Connolly","year":"2008","journal-title":"Am J Pathol"},{"key":"key20200714083519_b22-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"77","DOI":"10.7785\/tcrt.2012.500364","article-title":"MicroRNA-34a targets Bcl-2 and sensitizes human hepatocellular carcinoma cells to sorafenib treatment","volume":"13","author":"Yang","year":"2014","journal-title":"Technol Cancer Res Treat"},{"key":"key20200714083519_b23-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"e61054","DOI":"10.1371\/journal.pone.0061054","article-title":"Underexpression of miR-34a in hepatocellular carcinoma and its contribution towards enhancement of proliferating inhibitory effects of agents targeting c-MET","volume":"8","author":"Dang","year":"2013","journal-title":"PLoS One"},{"key":"key20200714083519_b24-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"6236","DOI":"10.1158\/0008-5472.CAN-14-0855","article-title":"A small-molecule modulator of the tumor-suppressor miR34a inhibits the growth of hepatocellular carcinoma","volume":"74","author":"Xiao","year":"2014","journal-title":"Cancer Res"},{"key":"key20200714083519_b25-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"2339","DOI":"10.1158\/0008-5472.CAN-09-2777","article-title":"MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta","volume":"70","author":"Tsukamoto","year":"2010","journal-title":"Cancer Res"},{"key":"key20200714083519_b26-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1038\/bjc.2013.308","article-title":"MiR-375 is upregulated in acquired paclitaxel resistance in cervical cancer","volume":"109","author":"Shen","year":"2013","journal-title":"Br J Cancer"},{"key":"key20200714083519_b27-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"1011","DOI":"10.1002\/ijc.28563","article-title":"The emerging role of miR-375 in cancer","volume":"135","author":"Yan","year":"2014","journal-title":"Int J Cancer"},{"key":"key20200714083519_b28-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"625","DOI":"10.3892\/etm.2015.2920","article-title":"Upregulation of microRNA-375 increases the cisplatin-sensitivity of human gastric cancer cells by regulating ERBB2","volume":"11","author":"Zhou","year":"2016","journal-title":"Exp Ther Med"},{"key":"key20200714083519_b29-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1007\/s13277-015-3921-1","article-title":"MiR-20a enhances cisplatin resistance of human gastric cancer cell line by targeting NFKBIB","volume":"37","author":"Du","year":"2016","journal-title":"Tumour Biol"},{"key":"key20200714083519_b30-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"key20200714083519_b31-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"1894","DOI":"10.1002\/ijc.24580","article-title":"Increased expression of ErbB-2 in liver is associated with hepatitis B \u00d7 antigen and shorter survival in patients with liver cancer","volume":"125","author":"Liu","year":"2009","journal-title":"Int J Cancer"},{"key":"key20200714083519_b32-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1038\/nrg3471","article-title":"Adult-specific functions of animal microRNAs","volume":"14","author":"Sun","year":"2013","journal-title":"Nat Rev Genet"},{"key":"key20200714083519_b33-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"849","DOI":"10.1038\/nrc3166","article-title":"Epigenetics and genetics. MicroRNAs en route to the clinic: Progress in validating and targeting microRNAs for cancer therapy","volume":"11","author":"Kasinski","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"key20200714083519_b34-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1002\/emmm.201100209","article-title":"MicroRNA dysregulation in cancer: Diagnostics, monitoring and therapeutics. A comprehensive review","volume":"4","author":"Iorio","year":"2012","journal-title":"EMBO Mol Med"},{"key":"key20200714083519_b35-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1101\/gad.1399806","article-title":"Control of translation and mRNA degradation by miRNAs and siRNAs","volume":"20","author":"Valencia-Sanchez","year":"2006","journal-title":"Genes Dev"},{"key":"key20200714083519_b36-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1038\/nature03076","article-title":"A pancreatic islet-specific microRNA regulates insulin secretion","volume":"432","author":"Poy","year":"2004","journal-title":"Nature"},{"key":"key20200714083519_b37-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"e5033","DOI":"10.1371\/journal.pone.0005033","article-title":"The promoter of the pri-miR-375 gene directs expression selectively to the endocrine pancreas","volume":"4","author":"Avnit-Sagi","year":"2009","journal-title":"PLoS One"},{"key":"key20200714083519_b38-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"623","DOI":"10.1016\/j.bbrc.2010.03.036","article-title":"MicroRNA-375 targets Hippo-signaling effector YAP in liver cancer and inhibits tumor properties","volume":"394","author":"Liu","year":"2010","journal-title":"Biochem Biophys Res Commun"},{"key":"key20200714083519_b39-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"5813","DOI":"10.1073\/pnas.0810550106","article-title":"MiR-375 maintains normal pancreatic alpha- and beta-cell mass","volume":"106","author":"Poy","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"key20200714083519_b40-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"e203","DOI":"10.1371\/journal.pbio.0050203","article-title":"Targeted inhibition of miRNA maturation with morpholinos reveals a role for miR-375 in pancreatic islet development","volume":"5","author":"Kloosterman","year":"2007","journal-title":"PLoS Biol"},{"key":"key20200714083519_b41-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"1757","DOI":"10.3892\/etm.2014.1627","article-title":"MiR-375 inhibits the proliferation of gastric cancer cells by repressing ERBB2 expression","volume":"7","author":"Shen","year":"2014","journal-title":"Exp Ther Med"},{"key":"key20200714083519_b42-ol-0-0-9011","doi-asserted-by":"publisher","first-page":"1808","DOI":"10.1159\/000356614","article-title":"MiR-375 inhibits proliferation of mouse pancreatic progenitor cells by targeting YAP1","volume":"32","author":"Zhang","year":"2013","journal-title":"Cell Physiol Biochem"},{"key":"key20200714083519_b43-ol-0-0-9011","first-page":"743193","article-title":"The HER2 receptor in breast cancer: Pathophysiology, clinical use, and new advances in therapy","volume":"2012","author":"Mitri","year":"2012","journal-title":"Chemother Res Pract"}],"container-title":["Oncology Letters"],"original-title":[],"deposited":{"date-parts":[[2020,7,14]],"date-time":"2020-07-14T09:27:57Z","timestamp":1594718877000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.spandidos-publications.com\/10.3892\/ol.2018.9011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,6,22]]},"references-count":43,"URL":"https:\/\/doi.org\/10.3892\/ol.2018.9011","relation":{},"ISSN":["1792-1074","1792-1082"],"issn-type":[{"value":"1792-1074","type":"print"},{"value":"1792-1082","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,6,22]]}}}